Catalyst Biosciences, Inc. (CBIO) financial statements (2021 and earlier)

Company profile

Business Address 611 GATEWAY BLVD., SUITE 710
SOUTH SAN FRANCISCO, CA 94080
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:8277120321733107
Cash and cash equivalents30153114102956
Short-term investments496189187351
Other undisclosed cash, cash equivalents, and short-term investments30(0)(0)00 
Restricted cash and investments  051934 
Receivables315 0000
Prepaid expense      1
Deposits current assets     0 
Other undisclosed current assets444112 
Total current assets:9096124393869108
Noncurrent Assets
Operating lease, right-of-use asset22
Property, plant and equipment0000010
Long-term investments and receivables3     3
Long-term investments3     3
Deposits noncurrent assets   0   
Restricted cash and investments    00 
Other noncurrent assets101   0
Total noncurrent assets:5210114
TOTAL ASSETS:9599125403870112
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities151353223
Accounts payable6411110
Accrued liabilities7721113
Employee-related liabilities221111 
Deferred revenue215
Debt 0 51934 
Deferred rent credit  0
Derivative instruments and hedges, liabilities     1 
Deferred revenue and credits000 
Other undisclosed current liabilities1      
Total current liabilities:18295922383
Noncurrent Liabilities
Long-term debt and lease obligation11     
Operating lease, liability11
Liabilities, other than long-term debt  0 00 
Deferred revenue and credits 00 
Deferred rent credit  0
Other undisclosed noncurrent liabilities(1)      
Total noncurrent liabilities:110 00 
Total liabilities:19305922383
Stockholders' equity
Stockholders' equity attributable to parent7668120311631109
Common stock0000000
Additional paid in capital391327323204164162422
Accumulated other comprehensive income (loss)00(0) (0)00
Accumulated deficit(315)(259)(203)(173)(148)(131)(313)
Total stockholders' equity:7668120311631109
TOTAL LIABILITIES AND EQUITY:9599125403870112

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenue, net1020
Gross profit:21 01020
Operating expenses(78)(57)(34)(23)(21)(16)(30)
Operating loss:(57)(57)(34)(22)(20)(14)(30)
Nonoperating income (expense)1(0)200 1
Investment income, nonoperating  0   1
Other nonoperating income (expense)1(0)200  
Interest and debt expense    0(1)(0)
Other undisclosed income from continuing operations before equity method investments, income taxes      0
Loss from continuing operations before income taxes:(57)(57)(32)(22)(20)(15)(29)
Income tax expense      (3)
Loss before gain (loss) on sale of properties:(57)(57)(32)(22)(20)(15)(33)
Other undisclosed net income022    
Net loss:(56)(55)(30)(22)(20)(15)(33)
Other undisclosed net income attributable to parent    31 
Net loss attributable to parent:(56)(55)(30)(22)(17)(15)(33)
Preferred stock dividends and other adjustments   (4)   
Net loss available to common stockholders, diluted:(56)(55)(30)(26)(17)(15)(33)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(56)(55)(30)(22)(20)(15)(33)
Other comprehensive loss      (0)
Comprehensive loss:(56)(55)(30)(22)(20)(15)(33)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)0(0)0310
Comprehensive loss, net of tax, attributable to parent:(56)(55)(30)(22)(17)(15)(33)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: